Fidelity International’s Cidara Therapeutics CDTX Stock Holding History

Fidelity International’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,257,574	Closed	-$278M	–	1119
2025 Q4	$278M	Buy	+1,257,574	New	+$203M	0.21%	128

Fidelity International's CDTX Position: Q1 2026 in Review

Fidelity International sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,257,574 shares — an estimated $278M sold.

Fidelity International first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $278M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Fidelity International reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Fidelity International sold 1,257,574 Cidara Therapeutics shares in Q1 2026, an estimated $278M.
Fidelity International first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Fidelity International's Cidara Therapeutics position peaked at $278M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Fidelity International's 13F filing for Q1 2026, filed 15 May 2026.